Suresh Kumar Pakalapati's Linux Administration: IBM Watson Health cuts back Drug Discovery 'artificial intelligence' after lackluster sales

Friday, April 19, 2019

IBM Watson Health cuts back Drug Discovery 'artificial intelligence' after lackluster sales - The Register

IBM Watson Health cuts back Drug Discovery 'artificial intelligence' after lackluster sales The Register

IBM Watson Health is tapering off its Drug Discovery program, which uses "AI" software to help companies develop new pharmaceuticals, blaming poor sales.